An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer.
Kong L, Meng F, Zhou P, Ge R, Geng X, Yang Z, Li G, Zhang L, Wang J, Ma J, Dong C, Zhou J, Wu S, Zhong D, Xie S.
Kong L, et al. Among authors: ge r.
Sci Bull (Beijing). 2024 May 18:S2095-9273(24)00351-7. doi: 10.1016/j.scib.2024.05.017. Online ahead of print.
Sci Bull (Beijing). 2024.
PMID: 38811338
Free article.